Highmount Capital’s AbbVie ABBV Stock Holding History

Highmount Capital’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	$3.52M	Buy	52,307 +47,850	+1,074%	+$3.12M	0.9%	29
2015 Q1	$261K	Buy	4,457 +750	+20%	+$45.3K	0.06%	122
2014 Q4	$242K	Hold	3,707	–	–	0.06%	122
2014 Q3	$214K	Hold	3,707	–	–	0.05%	134
2014 Q2	$209K	Buy	+3,707	New	+$194K	0.05%	140
2013 Q3	–	Sell	-5,402	Closed	-$223K	–	131
2013 Q2	$223K	Buy	+5,402	New	+$236K	0.06%	119

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Highmount Capital's ABBV Position: Q2 2015 in Review

Highmount Capital increased its AbbVie (ABBV) stake by 1,074% in Q2 2015, buying an estimated $3.12M and bringing the position to 52,307 shares worth $3.52M. The position accounts for 0.9% of the portfolio, ranked #29.

Highmount Capital first reported a position in ABBV in Q2 2013 and has held it in 6 quarters since. 1,654 funds tracked by Wall St. Rank hold ABBV as of Q2 2015.

Highmount Capital held 52,307 shares of AbbVie worth $3.52M as of Q2 2015.
Highmount Capital bought 47,850 AbbVie shares in Q2 2015, an estimated $3.12M.
AbbVie made up 0.9% of Highmount Capital's portfolio in Q2 2015, its #29 holding.
Highmount Capital first reported a position in AbbVie in Q2 2013 and has held it in 6 quarters since.
1,654 funds tracked by Wall St. Rank held AbbVie as of Q2 2015.

Based on Highmount Capital's 13F filing for Q2 2015, filed 14 Aug 2015.